IPEM, the only international private equity and venture capital marketplace has selected StemTek to attend its 3rd event at Cannes from the 24th to the 26th of January. IPEM offers an innovative format with private spaces and lounges to conduct appointments and facilitate productive meetings, along a conferences and workshops program and networking events designed to engender the exchange of ideas, experiences and viewpoints.    
New article in Cell Cycle that uses Cell2Sphere New article in Cell Cycle that uses our ready to us 3D cell culture solution, Cell2Spehre, as reference methodology to uncover novel therapeutic approaches in triple negative breast cancer.  Check it out!  
Bridge to MassChallenge Biscay 2017 winners   Stemtek Therapeutic´s CEO, Angel Garcia Martin, had the pleasure to be invited to participate in the Bridge to MassChalenge Biscay 2017, a boot camp that took place from March 20th to the 23rd at the MassChallenge´s flagship office in Boston, Massachusetts.   During this 4-day boot camp, all 12 selected entrepreneurs from the Basque Country and the representatives from BEAZ had the chance to attend amazing speaker...

StemTek Therapeutics Launches Cell2Sphere 3D Cell Culture Kit

Bilbao, Spain & Cologne, Germany - November 07, 2016

A geometric evolution of cell based assay development for drug discovery. StemTek Therapeutics, a leading Spanish biotech start up, today announced the availability of Cell2Sphere, an innovative 3D cell culture kit created specifically for use in cancer stem cell research, pharmaceutical drug development and personalized medicine. Cell2Sphere frozen spheroid tissue culture samples increase the shelf life of today’s 3D cultures, enhancing the biological relevance of pre-clinical in vi...
StemTek Therapeutics, a leading Spanish biotech start up with a stem cell centric approach, today announced an important collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC) part of the Spanish National Research Council (CSIC). The agreement enables greater access and deeper collaboration between the private and the public sector to screen libraries of compounds from the Institute for Advanced Chemistry of Catalonia in order to identify those that can be used ...
Back to top